EPISODE · Jul 16, 2026 · 9 MIN
The Disappointment of the NSABP C-08 Trial
from Oncology Times - OncTimes Talk
Norman Wolmark on the study's frustrating but unequivocal results showing that bevacizumab did not extend disease-free survival in adjuvant therapy for early colon cancer at 3 years, even though there had been a benefit at 1 year. Also weighing in: Nicholas Petrelli
Embed this episode
NOW PLAYING
The Disappointment of the NSABP C-08 Trial
0:00
9:05
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of Oncology Times - OncTimes Talk?
This episode is 9 minutes long.
When was this Oncology Times - OncTimes Talk episode published?
This episode was published on July 16, 2026.
Can I download this Oncology Times - OncTimes Talk episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!